At least 17 million people in Europe suffered long Covid in first 2 years of pandemic, WHO report says

At least 17 million people in Europe suffered long Covid in first 2 years of pandemic, WHO report says


New research suggests at least 17 million people across Europe and central Asia suffered from long Covid within the first two years of the pandemic.

Filadendron | E+ | Getty Images

At least 17 million people in Europe suffered from “long Covid” within the first two years of the coronavirus pandemic, according to a new study released Tuesday by the World Health Organization.

Around 10% to 20% of all Covid-19 cases reported in 2020 and 2021 across the region resulted in lingering effects lasting at least three months, with symptoms ranging from chronic fatigue to brain fog and breathlessness, the report found.

Women were also twice as likely as men to experience long Covid. Among serious cases resulting in hospitalization, one in three women were found to develop long-term symptoms.

The research, which was conducted by the Institute of Health Metrics and Evaluation at the University of Washington’s School of Medicine, pertains to the WHO’s Europe region, which is home to nearly 900 million people in 53 states across Europe and Central Asia.

‘Debilitating symptoms’

Long Covid refers to a range of mid- and long-term effects that can emerge following a Covid infection. Those can include fatigue, breathlessness and cognitive dysfunction, such as confusion and forgetfulness.

Some people’s mental health can also be impacted, either directly or indirectly.

While the majority of people fully recover from Covid, Dr. Hans Kluge, the WHO’s regional director for Europe, said the findings highlight the urgent need for more analysis and investment in monitoring the drawn out effects of the illness.

“Millions of people in our region, straddling Europe and central Asia, are suffering debilitating symptoms many months after their initial Covid-19 infection,” Kluge said.

Expedia CEO says travel is booming and business travelers are back

“They cannot continue to suffer in silence,” he continued. “Governments and health partners must collaborate to find solutions based on research and evidence.”

Cases of long Covid rose more than 300% in 2021 compared with 2020, in line with the drawn out nature of the illness, the study found.

Worldwide, 145 million people are estimated to have developed long Covid during 2020 and 2021, according to IHME data.

The director of IHME, Dr. Christopher Murray, said the findings should also raise awareness about the implications of long Covid for mental health and workplace wellbeing.

“Knowing how many people are affected and for how long is important for health systems and government agencies to develop rehabilitative and support services,” Murray said.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More